Neogen Corporation (NEOG) Price Target Analysis
Updated Jul 2, 2026
Analyst Rating: Hold
Based on 11 analysts17.1% Below Target
NEOG trades 17.1% below Wall Street's consensus target of $11.00.
Current Price$9.39
Average Target$11.00
Target
Current
Low$10.00
Median$11.00
High$12.00
Analyst Target Range
Forward P/E25.4x
(Growth Premium)
PEG Ratio—
Implied Growth+113.2%
(High Growth)
Analyst Spread18.2%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes NEOG achieves its forward estimates and maintains a stable P/E multiple of 25.4x. This scenario reflects the blended consensus of 11 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
NEOG Price Target Analysis
Updated July 8, 2026As of July 8, 2026, Neogen Corporation (NEOG) has a Wall Street consensus price target of $11.00, based on estimates from 11 covering analysts. With the stock currently trading at $9.39, this represents a potential upside of +17.1%. The company has a market capitalization of $2.04B.
Analyst price targets range from a low of $10.00 to a high of $12.00, representing a 18% spread in expectations. The median target of $11.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, NEOG trades at a trailing P/E of -1.9x and forward P/E of 25.4x. Analysts expect EPS to grow +113.2% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+19.4%
Industry Consensus
Avg Forward P/E
19.7x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 IDXXIDEXX Laboratories, Inc. | $45.3B | $570.25 | $747.50 | +31.1% | Buy | 38.9x | 22 |
 BCALSouthern California Bancorp | $663M | $20.61 | $22.00 | +6.7% | Buy | 12.3x | 3 |
 QDELQuidelOrtho Corporation | $1.2B | $17.00 | $12.25 | -27.9% | Hold | 9.2x | 15 |
 NVAXNovavax, Inc. | $1.6B | $9.46 | $18.00 | +90.3% | Buy | — | 23 |
 BIOBio-Rad Laboratories, Inc. | $7.9B | $292.50 | $321.67 | +10.0% | Buy | 32.4x | 14 |
 MESOMesoblast Limited | $1.8B | $14.29 | $11.50 | -19.5% | Buy | — | 11 |
 FELEFranklin Electric Co., Inc. | $4.5B | $102.77 | $100.00 | -2.7% | Hold | 22.4x | 11 |
 PRAXPraxis Precision Medicines, Inc. | $9.4B | $323.95 | $589.00 | +81.8% | Buy | — | 16 |
 TSNTyson Foods, Inc. | $20.9B | $58.82 | $73.00 | +24.1% | Buy | 14.6x | 30 |
 CAGConagra Brands, Inc. | $6.7B | $14.04 | $14.00 | -0.2% | Hold | 8.3x | 25 |
NEOG — Frequently Asked Questions
Quick answers to the most common questions about buying NEOG stock.
What is the NEOG stock price target for 2026?
Neogen Corporation (NEOG) has a consensus 12-month price target of $11, implying 17.1% upside from $9.39. The 11 analysts covering NEOG see moderate appreciation potential.
Is NEOG a buy, sell, or hold?
NEOG has a consensus rating of "Hold" based on 11 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $11 implies 17.1% upside from current levels.
Is NEOG stock overvalued or undervalued?
NEOG trades at a forward P/E of 25.3784x, representing a moderate valuation. With analysts targeting $11 (17.1% implied move), the stock appears reasonably valued with upside.
How high can NEOG stock go?
The most bullish Wall Street analyst has a price target of $12 for NEOG, while the most conservative target is $10. The consensus of $11 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover NEOG stock?
NEOG is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 6 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the NEOG stock forecast?
The 12-month NEOG stock forecast based on 11 Wall Street analysts shows a consensus price target of $11, with estimates ranging from $10 (bear case) to $12 (bull case). The median consensus rating is "Hold".
What is NEOG's forward P/E ratio?
NEOG trades at a forward P/E ratio of 25.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy NEOG stock?
Wall Street analysts are optimistic on NEOG, with a "Hold" consensus rating and $11 price target (17.1% upside). 4 of 11 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do NEOG price targets vary so much?
NEOG analyst price targets range from $10 to $12, a 18% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $11 consensus represents the middle ground.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare